June 23, 2021—RapidPulse, Inc. announced the closing of a $15 million Series A financing that the company plans to use to advance its RapidPulse cyclic aspiration system through expanded clinical evaluation and build out its platform of proprieta…
Category: endovascular
Penumbra’s Red 62 Reperfusion Catheter Cleared by FDA
June 23, 2021—Penumbra, Inc. announced FDA 510(k) clearance and commercial availability of the Red 62 reperfusion catheter, an addition to the Penumbra system for mechanical thrombectomy.
According to the company, Red 62 is designed to navigat…
Sensome’s Clotild AI-Powered Stroke Guidewire Receives FDA Breakthrough Device Designation
June 21, 2021—Sensome announced that it has been granted a Breakthrough Device designation by FDA for its Clotild smart guidewire system, which is designed to use artificial intelligence (AI) to improve the treatment of ischemic stroke patients.
…
Cagent Vascular Receives Investment to Support Commercialization of Serranator BTK Catheter
June 17, 2021—Cagent Vascular Inc. announced an investment of $9 million by Sectoral Asset Management, which Cagent will use to accelerate the commercialization and scaling of manufacturing for its Serranator below-the-knee (BTK) percutaneous tra…
Femoropopliteal bypass shows reintervention benefit over endovascular therapy for advanced premature PAD
Femoropopliteal bypass is associated with decreased reinterventions at one year compared to endovascular therapy in patients with advanced premature peripheral arterial disease (PAD). This is the primary conclusion of Tanner I Kim (Yale School of Medicine, New Haven, USA) and colleagues, writing in an article recently published online in the Journal of Vascular Surgery. The […]
The post Femoropopliteal bypass shows reintervention benefit over endovascular therapy for advanced premature PAD appeared first on Vascular News.
Updated Summary-Level Analysis of Paclitaxel-Coated Devices Shows No Evidence of Increased All-Cause Mortality Risk
June 15, 2021—In an updated systematic review and meta-analysis of randomized controlled trials (RCTs) of paclitaxel-coated device (PCD) use in patients with occlusive femoropopliteal disease, Dinh et al found no increased risk of all-cause morta…
SOCRATES Study Begins in Germany to Compare ESAR and FEVAR Treatments of AAA
June 15, 2021—St. Franziskus-Hospital in Münster, Germany, announced the commencement of the postmarket SOCRATES study comparing endosuture aneurysm repair (ESAR) to fenestrated endovascular aneurysm repair (FEVAR) in patients with ho…
Novel PET Radiotracer Studied to Diagnose AAA and Predict Rupture
June 15, 2021—The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced findings demonstrating that a new positron emission tomography (PET) radiotracer can detect abdominal aortic aneurysms (AAAs) and potentially predict when they …
Neurescue’s Intelligent Balloon Catheter Cleared by FDA for Hemorrhage Control
June 10, 2021—Neurescue, a Denmark-based developer of cardiovascular solutions to improve the outcomes for emergency patients, announced that the FDA has granted 510(k) clearance to market the company’s Neurescue device for temporary occlus…
Embolx Launches Sniper in Europe
June 8, 2021—Embolx Inc., a manufacturer of microcatheters for arterial embolization procedures, announced a limited release of its Sniper balloon occlusion microcatheter in the European market.
According to the company, the Sniper delivery sy…